CASE REPORT: Sarcoidosis After Use of Interferon for Chronic Hepatitis C: Report of a Case and Review of the Literature

Abstract

Interferon-α (IFNα) is widely used for the treatment of chronic hepatitis C (CHC) (1–4). Although adverse side effects during treatment are frequent, pulmonary side effects of IFN-α are uncommon (4–6). IFN may lead to the development or exacerbation of autoimmune phenomena and diseases, including sarcoidosis, because of the strong and complex immune action… (More)
DOI: 10.1023/A:1021759120428

3 Figures and Tables

Topics

  • Presentations referencing similar topics